PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-67.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-214.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
25.24%
Positive EBIT growth while RUN is negative. John Neff might see a substantial edge in operational management.
51.95%
Positive operating income growth while RUN is negative. John Neff might view this as a competitive edge in operations.
51.12%
Positive net income growth while RUN is negative. John Neff might see a big relative performance advantage.
51.26%
Positive EPS growth while RUN is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
51.26%
Positive diluted EPS growth while RUN is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.33%
Share count expansion well above RUN's 0.52%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.33%
Diluted share reduction more than 1.5x RUN's 2.34%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-126.11%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-145.35%
Negative FCF growth while RUN is at 10.28%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
22.72%
10Y revenue/share CAGR under 50% of RUN's 160.92%. Michael Burry would suspect a lasting competitive disadvantage.
-46.40%
Negative 5Y CAGR while RUN stands at 160.92%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-58.19%
Negative 3Y CAGR while RUN stands at 160.92%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-589.71%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
25.26%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
-321.17%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-5856.79%
Negative 10Y net income/share CAGR while RUN is at 182.73%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-45.21%
Negative 5Y net income/share CAGR while RUN is 182.73%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-281.88%
Negative 3Y CAGR while RUN is 182.73%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-30.93%
Negative equity/share CAGR over 10 years while RUN stands at 58.93%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-46.59%
Negative 5Y equity/share growth while RUN is at 58.93%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-36.42%
Negative 3Y equity/share growth while RUN is at 58.93%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while RUN stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-20.67%
Firm’s AR is declining while RUN shows 8.90%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.59%
We show growth while RUN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-5.27%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-13.05%
We have a declining book value while RUN shows 7.58%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
21.24%
Debt growth far above RUN's 4.54%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-14.02%
Our R&D shrinks while RUN invests at 3.13%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.33%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.